What is MoldTech?
MoldTech, LLC operates as a premier developer and manufacturer of custom rubber molded products, serving a diverse array of mission-critical sectors including aerospace, military, medical, and automotive industries. The company distinguishes itself through advanced manufacturing capabilities, which include specialized clean room environments essential for high-compliance medical device production. With certifications such as ISO/TS 16949 and ISO 13485, MoldTech has established a reputation for technical excellence and quality assurance. Its market position is defined by its ability to integrate custom equipment with complex elastomer science, providing bespoke solutions that address the unique engineering challenges of its industrial clientele. As a key player in the North American manufacturing landscape, the firm remains focused on delivering high-performance components that meet stringent regulatory and performance standards.
How much funding has MoldTech raised?
MoldTech has raised a total of $2M across 2 funding rounds:
Debt
$1M
Debt
$982K
Debt (2020): $1M with participation from PPP
Debt (2021): $982K led by PPP
Key Investors in MoldTech
PPP
Public-Private Partnership
What's next for MoldTech?
Looking ahead, MoldTech is positioned to capitalize on the increasing demand for high-precision rubber components within the medical and aerospace sectors. The recent influx of capital provides the necessary liquidity to further optimize its manufacturing infrastructure and potentially expand its clean room capacity. By prioritizing operational efficiency and technological integration, the company is well-equipped to maintain its competitive edge in a market that increasingly values quality-certified, custom-engineered solutions. Future strategic initiatives will likely focus on scaling production throughput while maintaining the rigorous standards that have defined its growth to date, ensuring long-term sustainability in an evolving industrial environment.
See full MoldTech company page
